Literature DB >> 18995969

Ghrelin/obestatin ratio in two populations with low bodyweight: constitutional thinness and anorexia nervosa.

Natacha Germain1, Bogdan Galusca, Dominique Grouselle, Delphine Frere, Virginie Tolle, Philippe Zizzari, François Lang, Jacques Epelbaum, Bruno Estour.   

Abstract

Constitutional thinness (CT) and anorexia nervosa (AN) are two categories of severely underweight subjects. Some appetite-regulating hormones display opposite levels in AN and CT. While levels of ghrelin, an orexigenic hormone, fit with the normal food intake in CT, the lack of efficacy of increased ghrelin levels in AN is not clear. Obestatin is a recently described peptide derived from the preproghrelin gene, reported to inhibit appetite in contrast to ghrelin. The aim of this study was to determine whether the circadian profile of obestatin, total and acylated ghrelin levels is different in CT subjects when compared with AN patients. Six-points circadian profiles of plasma obestatin, acylated ghrelin, total ghrelin and other hormonal and nutritional parameters were evaluated in four groups of young women: 10 CT, 15 restricting-type AN, 7 restored from AN and 9 control subjects. Obestatin circadian levels were significantly higher in AN (p<0.0001) while no difference was found between CT and control subjects. Acylated and total ghrelin were found increased in AN. Acylated ghrelin/obestatin and total ghrelin/obestatin were found decreased in AN compared to CT or C subjects (p<0.05). The percentage of acylated ghrelin was found decreased in CT group (p<0.05). The decreased ghrelin/obestatin ratio found in AN might participate in the restraint in nutriment intake of these patients. In contrast, in CT a lower percentage of acylated over total ghrelin might be considered in the aetiology of this condition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18995969     DOI: 10.1016/j.psyneuen.2008.10.001

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  26 in total

Review 1.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

Review 2.  Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Protein Pept Sci       Date:  2011-06       Impact factor: 3.272

Review 3.  Underweight but not underfat: is fat-free mass a key factor in constitutionally thin women?

Authors:  Mélina Bailly; Audrey Boscaro; Bruno Pereira; Daniel Courteix; Natacha Germain; Bogdan Galusca; Yves Boirie; David Thivel; Julien Verney
Journal:  Eur J Clin Nutr       Date:  2021-03-26       Impact factor: 4.016

Review 4.  Is constitutional thinness really different from anorexia nervosa? A systematic review and meta-analysis.

Authors:  Mélina Bailly; Audrey Boscaro; Bruno Pereira; Léonard Féasson; Yves Boirie; Natacha Germain; Bogdan Galusca; Daniel Courteix; David Thivel; Julien Verney
Journal:  Rev Endocr Metab Disord       Date:  2021-04-30       Impact factor: 6.514

Review 5.  The role of ghrelin, salivary secretions, and dental care in eating disorders.

Authors:  Takakazu Yagi; Hirotaka Ueda; Haruka Amitani; Akihiro Asakawa; Shouichi Miyawaki; Akio Inui
Journal:  Nutrients       Date:  2012-08-13       Impact factor: 5.717

6.  Comparison of a high-carbohydrate and high-protein breakfast effect on plasma ghrelin, obestatin, NPY and PYY levels in women with anorexia and bulimia nervosa.

Authors:  Dana Sedlackova; Jana Kopeckova; Hana Papezova; Vojtech Hainer; Hana Kvasnickova; Martin Hill; Jara Nedvidkova
Journal:  Nutr Metab (Lond)       Date:  2012-06-08       Impact factor: 4.169

7.  Ghrelin: central and peripheral implications in anorexia nervosa.

Authors:  Mathieu Méquinion; Fanny Langlet; Sara Zgheib; Suzanne Dickson; Bénédicte Dehouck; Christophe Chauveau; Odile Viltart
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-26       Impact factor: 5.555

8.  Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia.

Authors:  Timo D Müller; Diego Perez-Tilve; Jenny Tong; Paul T Pfluger; Matthias H Tschöp
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

Review 9.  Anorexia nervosa: a unified neurological perspective.

Authors:  Tasneem Fatema Hasan; Hunaid Hasan
Journal:  Int J Med Sci       Date:  2011-10-22       Impact factor: 3.738

Review 10.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.